supply-chain disruption — e.g. “Existe/n otro/s medicamento/s con el mismo principio activo y para la misma vía de administración.” (Spain)
Recent shortage history
Spain: resolved 4 Jun 2026 (began 28 May 2026)
Spain: resolved 25 Jun 2026 (began 13 May 2026)
Spain: resolved 4 Jun 2026 (began 22 Apr 2026)
Spain: resolved 25 Feb 2026 (began 18 Jan 2026)
Spain: resolved 16 Feb 2026 (began 8 Jan 2026)
Spain: resolved 16 Dec 2025 (began 25 Nov 2025)
Frequently asked questions
Is Cabergolina Teva currently in shortage?
Yes. As of the latest regulator updates, Cabergolina Teva has 1 active shortage notice across 1 country (Spain). Status is refreshed daily from official regulatory sources.
Why is Cabergolina Teva in shortage?
Regulators attribute the current Cabergolina Teva shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
When will the Cabergolina Teva shortage be resolved?
Regulator-estimated resolution dates currently range from 19 Oct 2026 to 19 Oct 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Where does this Cabergolina Teva shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Data on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.